Log In
BCIQ
Print this Print this
 

E7974

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionHemiasterlin type tubulin polymerization inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerNanoCarrier Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/23/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today